New Phase 1 NCI trial

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jonzobot

Rank: President [?]

Points: 2527 [?]

Votes: 20 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

New Phase 1 NCI trial

posted on May 24, 2023 05:43PM

Not sure if anyone has noticed, but there's a new NCI trial listed for ZEN-3694 in combination with Capecitabine in advanced solid tumors.

NCT05803382

That brings the NCI collaboration to 8 trials, including one phase 2.

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply